Bicara Therapeutics (BCAX) Enterprise Value

Enterprise Value

$117.15 M
+$39.12 M+50.14%

Mon, 24 Feb 2025 22:57:39 GMT


Summary


Performance

BCAX Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherBCAXvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

BCAX Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+50.1%+6.5%+6.5%
1 m1 month+201.1%+14.0%+14.0%
3 m3 months-62.5%-23.4%-23.4%
6 m6 months---
ytdytd-58.4%-20.5%-20.5%
1 y1 year---
5 y5 years---

BCAX Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-monthat high$16 M+637.3%
3 m3-month$453 M-74.1%$14 M+762.2%
6 m6-month$1.04 B-88.8%$14 M+762.2%
1 y1-year$1.04 B-88.8%$14 M+762.2%
3 y3-year$1.04 B-88.8%$14 M+762.2%
5 y5-year$1.04 B-88.8%$14 M+762.2%
alltimeall time$1.04 B-88.8%$14 M+762.2%

Bicara Therapeutics Enterprise Value History

DateValue
2025
$117.15 M(-58.4%)
DateValue
2024
$281.46 M

FAQ

  • What is Bicara Therapeutics enterprise value?
  • What is the all time high enterprise value for Bicara Therapeutics?
  • What is BCAX enterprise value year-to-date change?

What is Bicara Therapeutics enterprise value?

The current enterprise value of BCAX is $117.15 M

What is the all time high enterprise value for Bicara Therapeutics?

Bicara Therapeutics all-time high enterprise value is $1.04 B

What is BCAX enterprise value year-to-date change?

Bicara Therapeutics enterprise value has changed by -$164.31 M (-58.38%) since the beginning of the year